CEACAM8 and gastric carcinoma: We then divided this cohort into (1) primarily resected gastric carcinomas and (2) neoadjuvant-treated tumors:(1) For all 268 patients within the first sub-cohort of the primarily resected gastric carcinoma the CD66b status could be determined.